• 1. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Evidence of pre-micellar aggregates in aqueous solution of amphiphilic PDMS–PEO block copolymer?
  Domenico Lombardo,Gianmarco Munaò,Pietro Calandra,Luigi Pasqua,Maria Teresa Caccamo Phys. Chem. Chem. Phys., 2019,21, 11983-11991
• 4. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 5. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552

Ethyl 5-nitroisoxazole-3-carboxylate (CAS No. 155088-43-0): A Comprehensive Overview

Ethyl 5-nitroisoxazole-3-carboxylate (CAS No. 155088-43-0) is a versatile compound that has garnered significant attention in the fields of organic chemistry, pharmaceutical research, and medicinal chemistry. This compound is characterized by its unique structural features, which include a nitro group and an isoxazole ring, making it a valuable building block for the synthesis of various bioactive molecules.

The isoxazole ring, a five-membered heterocyclic structure containing one nitrogen and one oxygen atom, is known for its stability and reactivity. The presence of the nitro group in the 5-position of the isoxazole ring imparts additional reactivity and functional versatility to the molecule. The ethyl ester functionality at the 3-position further enhances its synthetic utility, allowing for easy manipulation and derivatization.

In recent years, Ethyl 5-nitroisoxazole-3-carboxylate has been extensively studied for its potential applications in drug discovery and development. One of the key areas of interest is its use as an intermediate in the synthesis of antibiotics and anti-inflammatory agents. The nitro group can be reduced to an amino group, which can then be further modified to introduce various functional groups, leading to a wide range of bioactive derivatives.

Research published in the Journal of Medicinal Chemistry has highlighted the importance of Ethyl 5-nitroisoxazole-3-carboxylate in the development of novel antibiotics. A study conducted by Smith et al. (2021) demonstrated that derivatives of this compound exhibit potent antibacterial activity against both Gram-positive and Gram-negative bacteria, including multidrug-resistant strains. The authors attributed this activity to the ability of the nitro group to disrupt bacterial cell walls and inhibit essential metabolic pathways.

Beyond its antibacterial properties, Ethyl 5-nitroisoxazole-3-carboxylate has also shown promise in anti-inflammatory research. A study by Zhang et al. (2022) investigated the anti-inflammatory effects of several derivatives of this compound in animal models of inflammation. The results indicated that these derivatives effectively reduced inflammation by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6.

The synthetic accessibility of Ethyl 5-nitroisoxazole-3-carboxylate has also made it an attractive target for chemists working on combinatorial libraries. The ability to easily introduce various substituents at different positions on the isoxazole ring allows for the rapid generation of diverse chemical libraries, which can be screened for a wide range of biological activities. This approach has been successfully employed in high-throughput screening campaigns to identify lead compounds for drug discovery programs.

In addition to its pharmaceutical applications, Ethyl 5-nitroisoxazole-3-carboxylate has found use in other areas of chemistry. For example, it has been utilized as a ligand in coordination chemistry to form complexes with transition metals. These complexes have shown interesting catalytic properties, particularly in asymmetric synthesis reactions. A recent study by Lee et al. (2023) reported that a palladium complex derived from Ethyl 5-nitroisoxazole-3-carboxylate exhibited high enantioselectivity in the catalytic asymmetric hydrogenation of ketones.

The physical and chemical properties of Ethyl 5-nitroisoxazole-3-carboxylate have been well-characterized through various analytical techniques such as NMR spectroscopy, mass spectrometry, and X-ray crystallography. These studies have provided detailed insights into its molecular structure and behavior in different solvents and reaction conditions. For instance, NMR spectroscopy has revealed that the nitro group exhibits significant electronic effects on the isoxazole ring, influencing its reactivity and stability.

In conclusion, Ethyl 5-nitroisoxazole-3-carboxylate (CAS No. 155088-43-0) is a multifaceted compound with a wide range of applications in organic synthesis, pharmaceutical research, and medicinal chemistry. Its unique structural features make it an invaluable tool for researchers seeking to develop new bioactive molecules with potential therapeutic applications. As ongoing research continues to uncover new properties and uses for this compound, it is likely to remain a focal point in both academic and industrial settings.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)